March 3, 2010
The National Institute for Health and Clinical Excellence (NICE) published their preliminary decision on 24th December 2009, not to recommend the use of the antiarrhythmic, dronedarone, for the treatment of atrial fibrillation (AF) patients on the NHS. The decision has been met with protests from the medical community, politicians and the heart rhythm charity, Arrhythmia Alliance.
Log in or Register now.
Sign up for our regular email newsletters & be the first to know about fresh articles and site updates.